| Period Ending | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 |
|---|
|
Total Revenue
|
5,528,000
|
6,242,000
|
6,242,000
|
6,487,000
| | Cost of Revenue | 2,854,000 | 3,859,000 | 3,758,000 | 3,993,000 | | |
Gross Profit
|
2,674,000
|
2,383,000
|
2,484,000
|
2,494,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 517,000 | 599,000 | 500,000 | 596,000 |
|
Non Recurring |
-
| 14,000 | 10,000 | 16,000 |
|
Others | 5,000 | 5,000 | 5,000 | 5,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
2,152,000
|
1,765,000
|
1,969,000
|
1,877,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 2,147,000 | 1,758,000 | 1,043,000 | 1,807,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 2,147,000 | 1,758,000 | 1,043,000 | 1,807,000 |
|
Income Tax Expense | 762,000 | 653,000 | 386,000 | 581,000 |
|
Minority Interest |
-
| (2,000) |
-
| (1,000) |
|
|
|
Net Income From Continuing Ops | 1,641,000 | 1,354,000 | 13,000 | 1,448,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
1,385,000
|
1,103,000
|
657,000
|
1,225,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,385,000
|
1,103,000
|
657,000
|
1,225,000
|
|
1.77%